These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36583759)

  • 1. A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension.
    Ishikawa T; Egusa M; Fujioka T; Nishiyama N; Kawamoto D; Sasaki R; Nishimura T; Tanabe N; Oono T; Saeki I; Takami T
    J Gastroenterol; 2023 Mar; 58(3):246-256. PubMed ID: 36583759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Hepatic Reserve and Fibrosis in a Case of "Portal-Systemic Liver Failure" by Portosystemic Shunt Occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Iwamoto T; Takami T; Yamasaki T; Sakaida I
    Am J Case Rep; 2020 Feb; 21():e921236. PubMed ID: 32063601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Young S; Rostambeigi N; Golzarian J; Lim N
    AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures].
    Wen L; He S; Zhang H; Luo X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):514-8. PubMed ID: 25203803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
    Song J; Wang X; Yan Y; Xiang T; Luo X
    Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
    Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
    Ahmed R; Santhanam P; Rayyan Y
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1226-7. PubMed ID: 26111072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
    Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
    Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    Wang YB; Zhang JY; Gong JP; Zhang F; Zhao Y
    J Gastroenterol Hepatol; 2016 Apr; 31(4):727-33. PubMed ID: 26637789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count.
    Saad WE; Bleibel W; Adenaw N; Wagner CE; Anderson C; Angle JF; Al-Osaimi AM; Davies MG; Caldwell S
    J Clin Imaging Sci; 2014; 4():24. PubMed ID: 24987571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up.
    Stein DJ; Salinas C; Sabri S; Onyeali R; Caldwell S; Henry Z
    J Vasc Interv Radiol; 2019 Feb; 30(2):187-194. PubMed ID: 30717949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt.
    Sturm L; Praktiknjo M; Bettinger D; Huber JP; Volkwein L; Schmidt A; Kaeser R; Chang J; Jansen C; Meyer C; Thomas D; Thimme R; Trebicka J; Schultheiß M
    Hepatol Commun; 2021 Apr; 5(4):650-660. PubMed ID: 33860123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.
    Zhao Y; Wang Y; Xu J
    Acad Radiol; 2024 Sep; 31(9):3688-3710. PubMed ID: 38000922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
    Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
    Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.